Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis Article Swipe
Xiaoxiao Liu
,
Chunying Zhuang
,
Lei Liu
,
Ling Xiong
,
Xin Xie
,
Ping He
,
Juanjuan Li
,
Bing Wei
,
Xi Yan
,
Tinglun Tian
,
Xiaorong Zhong
,
Jie Chen
,
Cheng Yan
,
Dan Zheng
,
Cheng Peng
,
Tianlin Sun
,
Weiwei Li
,
Changbin Zhu
,
Shuaitong Chen
,
Chao Fang
,
Jun Fu
,
Shibao Li
,
Jing Jing
,
Ting Luo
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41392-025-02337-1
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41392-025-02337-1
Related Topics
Concepts
Apatinib
Medicine
Oncology
Chemotherapy
Triple-negative breast cancer
Breast cancer
Antibody
Internal medicine
Neoadjuvant therapy
Cancer
Immunology
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41392-025-02337-1
- https://www.nature.com/articles/s41392-025-02337-1.pdf
- OA Status
- gold
- Cited By
- 1
- References
- 50
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412525420
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412525420Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41392-025-02337-1Digital Object Identifier
- Title
-
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysisWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-21Full publication date if available
- Authors
-
Xiaoxiao Liu, Chunying Zhuang, Lei Liu, Ling Xiong, Xin Xie, Ping He, Juanjuan Li, Bing Wei, Xi Yan, Tinglun Tian, Xiaorong Zhong, Jie Chen, Cheng Yan, Dan Zheng, Cheng Peng, Tianlin Sun, Weiwei Li, Changbin Zhu, Shuaitong Chen, Chao Fang, Jun Fu, Shibao Li, Jing Jing, Ting LuoList of authors in order
- Landing page
-
https://doi.org/10.1038/s41392-025-02337-1Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s41392-025-02337-1.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41392-025-02337-1.pdfDirect OA link when available
- Concepts
-
Apatinib, Medicine, Oncology, Chemotherapy, Triple-negative breast cancer, Breast cancer, Antibody, Internal medicine, Neoadjuvant therapy, Cancer, ImmunologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
50Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412525420 |
|---|---|
| doi | https://doi.org/10.1038/s41392-025-02337-1 |
| ids.doi | https://doi.org/10.1038/s41392-025-02337-1 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40691458 |
| ids.openalex | https://openalex.org/W4412525420 |
| fwci | 3.27053909 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D005260 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Female |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D064726 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[3].qualifier_ui | Q000473 |
| mesh[3].descriptor_ui | D064726 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | pathology |
| mesh[3].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[4].qualifier_ui | Q000235 |
| mesh[4].descriptor_ui | D064726 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | genetics |
| mesh[4].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008875 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Middle Aged |
| mesh[6].qualifier_ui | Q000008 |
| mesh[6].descriptor_ui | D061067 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | administration & dosage |
| mesh[6].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[7].qualifier_ui | Q000009 |
| mesh[7].descriptor_ui | D061067 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | adverse effects |
| mesh[7].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[8].qualifier_ui | Q000494 |
| mesh[8].descriptor_ui | D061067 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | pharmacology |
| mesh[8].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000328 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Adult |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D020360 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Neoadjuvant Therapy |
| mesh[11].qualifier_ui | Q000008 |
| mesh[11].descriptor_ui | D011725 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | administration & dosage |
| mesh[11].descriptor_name | Pyridines |
| mesh[12].qualifier_ui | Q000494 |
| mesh[12].descriptor_ui | D011725 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | pharmacology |
| mesh[12].descriptor_name | Pyridines |
| mesh[13].qualifier_ui | Q000009 |
| mesh[13].descriptor_ui | D011725 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | adverse effects |
| mesh[13].descriptor_name | Pyridines |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D000971 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[15].qualifier_ui | Q000009 |
| mesh[15].descriptor_ui | D000971 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | adverse effects |
| mesh[15].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D000971 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000368 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Aged |
| mesh[18].qualifier_ui | Q000037 |
| mesh[18].descriptor_ui | D061026 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | antagonists & inhibitors |
| mesh[18].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[19].qualifier_ui | Q000235 |
| mesh[19].descriptor_ui | D014408 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | genetics |
| mesh[19].descriptor_name | Biomarkers, Tumor |
| mesh[20].qualifier_ui | Q000008 |
| mesh[20].descriptor_ui | D015251 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | administration & dosage |
| mesh[20].descriptor_name | Epirubicin |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D005260 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Female |
| mesh[23].qualifier_ui | Q000188 |
| mesh[23].descriptor_ui | D064726 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | drug therapy |
| mesh[23].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[24].qualifier_ui | Q000473 |
| mesh[24].descriptor_ui | D064726 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | pathology |
| mesh[24].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[25].qualifier_ui | Q000235 |
| mesh[25].descriptor_ui | D064726 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | genetics |
| mesh[25].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008875 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Middle Aged |
| mesh[27].qualifier_ui | Q000008 |
| mesh[27].descriptor_ui | D061067 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | administration & dosage |
| mesh[27].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[28].qualifier_ui | Q000009 |
| mesh[28].descriptor_ui | D061067 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | adverse effects |
| mesh[28].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[29].qualifier_ui | Q000494 |
| mesh[29].descriptor_ui | D061067 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | pharmacology |
| mesh[29].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000328 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Adult |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D020360 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Neoadjuvant Therapy |
| mesh[32].qualifier_ui | Q000008 |
| mesh[32].descriptor_ui | D011725 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | administration & dosage |
| mesh[32].descriptor_name | Pyridines |
| mesh[33].qualifier_ui | Q000494 |
| mesh[33].descriptor_ui | D011725 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | pharmacology |
| mesh[33].descriptor_name | Pyridines |
| mesh[34].qualifier_ui | Q000009 |
| mesh[34].descriptor_ui | D011725 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | adverse effects |
| mesh[34].descriptor_name | Pyridines |
| mesh[35].qualifier_ui | Q000627 |
| mesh[35].descriptor_ui | D000971 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | therapeutic use |
| mesh[35].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[36].qualifier_ui | Q000009 |
| mesh[36].descriptor_ui | D000971 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | adverse effects |
| mesh[36].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[37].qualifier_ui | Q000008 |
| mesh[37].descriptor_ui | D000971 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | administration & dosage |
| mesh[37].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D000368 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Aged |
| mesh[39].qualifier_ui | Q000037 |
| mesh[39].descriptor_ui | D061026 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | antagonists & inhibitors |
| mesh[39].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[40].qualifier_ui | Q000235 |
| mesh[40].descriptor_ui | D014408 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | genetics |
| mesh[40].descriptor_name | Biomarkers, Tumor |
| mesh[41].qualifier_ui | Q000008 |
| mesh[41].descriptor_ui | D015251 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | administration & dosage |
| mesh[41].descriptor_name | Epirubicin |
| type | article |
| title | Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis |
| biblio.issue | 1 |
| biblio.volume | 10 |
| biblio.last_page | 237 |
| biblio.first_page | 237 |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T10755 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9986000061035156 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | HER2/EGFR in Cancer Research |
| topics[2].id | https://openalex.org/T11491 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9984999895095825 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | CAR-T cell therapy research |
| is_xpac | False |
| apc_list.value | 1935 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2373 |
| apc_paid.value | 1935 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2373 |
| concepts[0].id | https://openalex.org/C2780668389 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9728456735610962 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q27262801 |
| concepts[0].display_name | Apatinib |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6669265031814575 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C143998085 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5736284852027893 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[2].display_name | Oncology |
| concepts[3].id | https://openalex.org/C2776694085 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5635468363761902 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[3].display_name | Chemotherapy |
| concepts[4].id | https://openalex.org/C2780110267 |
| concepts[4].level | 4 |
| concepts[4].score | 0.545192301273346 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7843332 |
| concepts[4].display_name | Triple-negative breast cancer |
| concepts[5].id | https://openalex.org/C530470458 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5155527591705322 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[5].display_name | Breast cancer |
| concepts[6].id | https://openalex.org/C159654299 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5116784572601318 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[6].display_name | Antibody |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.42320334911346436 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C2778292576 |
| concepts[8].level | 4 |
| concepts[8].score | 0.41639983654022217 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q6991934 |
| concepts[8].display_name | Neoadjuvant therapy |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.38704714179039 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.19990035891532898 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| keywords[0].id | https://openalex.org/keywords/apatinib |
| keywords[0].score | 0.9728456735610962 |
| keywords[0].display_name | Apatinib |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6669265031814575 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/oncology |
| keywords[2].score | 0.5736284852027893 |
| keywords[2].display_name | Oncology |
| keywords[3].id | https://openalex.org/keywords/chemotherapy |
| keywords[3].score | 0.5635468363761902 |
| keywords[3].display_name | Chemotherapy |
| keywords[4].id | https://openalex.org/keywords/triple-negative-breast-cancer |
| keywords[4].score | 0.545192301273346 |
| keywords[4].display_name | Triple-negative breast cancer |
| keywords[5].id | https://openalex.org/keywords/breast-cancer |
| keywords[5].score | 0.5155527591705322 |
| keywords[5].display_name | Breast cancer |
| keywords[6].id | https://openalex.org/keywords/antibody |
| keywords[6].score | 0.5116784572601318 |
| keywords[6].display_name | Antibody |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.42320334911346436 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/neoadjuvant-therapy |
| keywords[8].score | 0.41639983654022217 |
| keywords[8].display_name | Neoadjuvant therapy |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.38704714179039 |
| keywords[9].display_name | Cancer |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.19990035891532898 |
| keywords[10].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.1038/s41392-025-02337-1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2739142469 |
| locations[0].source.issn | 2059-3635, 2095-9907 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2059-3635 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Signal Transduction and Targeted Therapy |
| locations[0].source.host_organization | https://openalex.org/P4310319965 |
| locations[0].source.host_organization_name | Springer Nature |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319965 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s41392-025-02337-1.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Signal Transduction and Targeted Therapy |
| locations[0].landing_page_url | https://doi.org/10.1038/s41392-025-02337-1 |
| locations[1].id | pmid:40691458 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Signal transduction and targeted therapy |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40691458 |
| locations[2].id | pmh:oai:doaj.org/article:f885c03ec1fb4a32b8a3eaa9ab3b8fb7 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Signal Transduction and Targeted Therapy, Vol 10, Iss 1, Pp 1-13 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/f885c03ec1fb4a32b8a3eaa9ab3b8fb7 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:12279984 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Signal Transduct Target Ther |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12279984 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5119268647 |
| authorships[0].author.orcid | https://orcid.org/0009-0007-2086-3005 |
| authorships[0].author.display_name | Xiaoxiao Liu |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[0].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I24185976 |
| authorships[0].affiliations[1].raw_affiliation_string | Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I177388780 |
| authorships[0].affiliations[2].raw_affiliation_string | Department of Radiation Oncology, Cancer Center, Affiliated Hospital of Xuzhou Medical University; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I24185976 |
| authorships[0].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Sichuan University |
| authorships[0].institutions[1].id | https://openalex.org/I177388780 |
| authorships[0].institutions[1].ror | https://ror.org/04fe7hy80 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I177388780 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Xuzhou Medical College |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Xiaoxiao Liu |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Radiation Oncology, Cancer Center, Affiliated Hospital of Xuzhou Medical University; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. [email protected]., Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]., Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| authorships[1].author.id | https://openalex.org/A5089206858 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2602-0160 |
| authorships[1].author.display_name | Chunying Zhuang |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[1].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[1].institutions[0].id | https://openalex.org/I24185976 |
| authorships[1].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Sichuan University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Chunying Zhuang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[2].author.id | https://openalex.org/A5052249181 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5918-9774 |
| authorships[2].author.display_name | Lei Liu |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I177388780 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of physiology, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I177388780 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[2].institutions[0].id | https://openalex.org/I177388780 |
| authorships[2].institutions[0].ror | https://ror.org/04fe7hy80 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I177388780 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Xuzhou Medical College |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Lei Liu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China., Department of physiology, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[3].author.id | https://openalex.org/A5108239948 |
| authorships[3].author.orcid | https://orcid.org/0009-0004-7659-0577 |
| authorships[3].author.display_name | Ling Xiong |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[3].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[3].institutions[0].id | https://openalex.org/I24185976 |
| authorships[3].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Sichuan University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ling Xiong |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[4].author.id | https://openalex.org/A5027272944 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6784-4860 |
| authorships[4].author.display_name | Xin Xie |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I177388780 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Cancer Center, Affiliated Hospital of Xuzhou Medical University; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[4].institutions[0].id | https://openalex.org/I177388780 |
| authorships[4].institutions[0].ror | https://ror.org/04fe7hy80 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I177388780 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Xuzhou Medical College |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Xin Xie |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Radiation Oncology, Cancer Center, Affiliated Hospital of Xuzhou Medical University; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[5].author.id | https://openalex.org/A5102856461 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2599-4016 |
| authorships[5].author.display_name | Ping He |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[5].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[5].institutions[0].id | https://openalex.org/I24185976 |
| authorships[5].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Sichuan University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ping He |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[6].author.id | https://openalex.org/A5100733036 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0074-1453 |
| authorships[6].author.display_name | Juanjuan Li |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I177388780 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Cancer Center, Affiliated Hospital of Xuzhou Medical University; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[6].institutions[0].id | https://openalex.org/I177388780 |
| authorships[6].institutions[0].ror | https://ror.org/04fe7hy80 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I177388780 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Xuzhou Medical College |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Juanjuan Li |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Radiation Oncology, Cancer Center, Affiliated Hospital of Xuzhou Medical University; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. |
| authorships[7].author.id | https://openalex.org/A5080451542 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2334-4589 |
| authorships[7].author.display_name | Bing Wei |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I24185976, https://openalex.org/I4210089761 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[7].institutions[0].id | https://openalex.org/I24185976 |
| authorships[7].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Sichuan University |
| authorships[7].institutions[1].id | https://openalex.org/I4210089761 |
| authorships[7].institutions[1].ror | https://ror.org/007mrxy13 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210089761 |
| authorships[7].institutions[1].country_code | CN |
| authorships[7].institutions[1].display_name | West China Hospital of Sichuan University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Bing Wei |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[8].author.id | https://openalex.org/A5088223531 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-8439-9087 |
| authorships[8].author.display_name | Xi Yan |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[8].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[8].institutions[0].id | https://openalex.org/I24185976 |
| authorships[8].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Sichuan University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Xi Yan |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[9].author.id | https://openalex.org/A5112654544 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Tinglun Tian |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[9].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[9].institutions[0].id | https://openalex.org/I24185976 |
| authorships[9].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Sichuan University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Tinglun Tian |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[10].author.id | https://openalex.org/A5036867616 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1812-7213 |
| authorships[10].author.display_name | Xiaorong Zhong |
| authorships[10].countries | CN |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[10].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[10].institutions[0].id | https://openalex.org/I24185976 |
| authorships[10].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | Sichuan University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Xiaorong Zhong |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[11].author.id | https://openalex.org/A5100659919 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-7962-0840 |
| authorships[11].author.display_name | Jie Chen |
| authorships[11].countries | CN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Breast Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I24185976 |
| authorships[11].affiliations[1].raw_affiliation_string | Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[11].institutions[0].id | https://openalex.org/I24185976 |
| authorships[11].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Sichuan University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jie Chen |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Breast Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China., Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[12].author.id | https://openalex.org/A5100378083 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-4909-439X |
| authorships[12].author.display_name | Cheng Yan |
| authorships[12].countries | CN |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[12].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[12].institutions[0].id | https://openalex.org/I24185976 |
| authorships[12].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | Sichuan University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Yan Cheng |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[13].author.id | https://openalex.org/A5031245030 |
| authorships[13].author.orcid | https://orcid.org/0009-0007-6377-8177 |
| authorships[13].author.display_name | Dan Zheng |
| authorships[13].countries | CN |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[13].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[13].institutions[0].id | https://openalex.org/I24185976 |
| authorships[13].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[13].institutions[0].country_code | CN |
| authorships[13].institutions[0].display_name | Sichuan University |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Dan Zheng |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. |
| authorships[14].author.id | https://openalex.org/A5013206062 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-0220-5128 |
| authorships[14].author.display_name | Cheng Peng |
| authorships[14].countries | CN |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210150111 |
| authorships[14].affiliations[0].raw_affiliation_string | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[14].institutions[0].id | https://openalex.org/I4210150111 |
| authorships[14].institutions[0].ror | https://ror.org/05rbz8029 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210150111 |
| authorships[14].institutions[0].country_code | CN |
| authorships[14].institutions[0].display_name | Dian Diagnostics (China) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Peng Cheng |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[15].author.id | https://openalex.org/A5110670419 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Tianlin Sun |
| authorships[15].countries | CN |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210150111 |
| authorships[15].affiliations[0].raw_affiliation_string | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[15].institutions[0].id | https://openalex.org/I4210150111 |
| authorships[15].institutions[0].ror | https://ror.org/05rbz8029 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210150111 |
| authorships[15].institutions[0].country_code | CN |
| authorships[15].institutions[0].display_name | Dian Diagnostics (China) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Tianlin Sun |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[16].author.id | https://openalex.org/A5100371202 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-9145-8639 |
| authorships[16].author.display_name | Weiwei Li |
| authorships[16].countries | CN |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210150111 |
| authorships[16].affiliations[0].raw_affiliation_string | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[16].institutions[0].id | https://openalex.org/I4210150111 |
| authorships[16].institutions[0].ror | https://ror.org/05rbz8029 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210150111 |
| authorships[16].institutions[0].country_code | CN |
| authorships[16].institutions[0].display_name | Dian Diagnostics (China) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Weiwei Li |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[17].author.id | https://openalex.org/A5112575387 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Changbin Zhu |
| authorships[17].countries | CN |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210150111 |
| authorships[17].affiliations[0].raw_affiliation_string | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[17].institutions[0].id | https://openalex.org/I4210150111 |
| authorships[17].institutions[0].ror | https://ror.org/05rbz8029 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210150111 |
| authorships[17].institutions[0].country_code | CN |
| authorships[17].institutions[0].display_name | Dian Diagnostics (China) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Changbin Zhu |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Translational Medicine Department, Amoy Diagnostics Co., Ltd., Xiamen, Fujian, 361000, China. |
| authorships[18].author.id | https://openalex.org/A5037477656 |
| authorships[18].author.orcid | https://orcid.org/0009-0003-5047-8280 |
| authorships[18].author.display_name | Shuaitong Chen |
| authorships[18].countries | CN |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210142178 |
| authorships[18].affiliations[0].raw_affiliation_string | LC-Bio Technology Co., Ltd., Hangzhou, Zhejiang, 310000, China. |
| authorships[18].institutions[0].id | https://openalex.org/I4210142178 |
| authorships[18].institutions[0].ror | https://ror.org/04hy71c73 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210142178 |
| authorships[18].institutions[0].country_code | CN |
| authorships[18].institutions[0].display_name | Hangzhou DAC Biotech (China) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Shuaitong Chen |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | LC-Bio Technology Co., Ltd., Hangzhou, Zhejiang, 310000, China. |
| authorships[19].author.id | https://openalex.org/A5101655683 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-9807-6366 |
| authorships[19].author.display_name | Chao Fang |
| authorships[19].countries | CN |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210142178 |
| authorships[19].affiliations[0].raw_affiliation_string | LC-Bio Technology Co., Ltd., Hangzhou, Zhejiang, 310000, China. |
| authorships[19].institutions[0].id | https://openalex.org/I4210142178 |
| authorships[19].institutions[0].ror | https://ror.org/04hy71c73 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210142178 |
| authorships[19].institutions[0].country_code | CN |
| authorships[19].institutions[0].display_name | Hangzhou DAC Biotech (China) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Chao Fang |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | LC-Bio Technology Co., Ltd., Hangzhou, Zhejiang, 310000, China. |
| authorships[20].author.id | https://openalex.org/A5049402891 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-5200-4623 |
| authorships[20].author.display_name | Jun Fu |
| authorships[20].countries | CN |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210142178 |
| authorships[20].affiliations[0].raw_affiliation_string | LC-Bio Technology Co., Ltd., Hangzhou, Zhejiang, 310000, China. |
| authorships[20].institutions[0].id | https://openalex.org/I4210142178 |
| authorships[20].institutions[0].ror | https://ror.org/04hy71c73 |
| authorships[20].institutions[0].type | company |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210142178 |
| authorships[20].institutions[0].country_code | CN |
| authorships[20].institutions[0].display_name | Hangzhou DAC Biotech (China) |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Jun Fu |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | LC-Bio Technology Co., Ltd., Hangzhou, Zhejiang, 310000, China. |
| authorships[21].author.id | https://openalex.org/A5037300888 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-4026-4508 |
| authorships[21].author.display_name | Shibao Li |
| authorships[21].countries | CN |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I177388780 |
| authorships[21].affiliations[0].raw_affiliation_string | Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. [email protected]. |
| authorships[21].institutions[0].id | https://openalex.org/I177388780 |
| authorships[21].institutions[0].ror | https://ror.org/04fe7hy80 |
| authorships[21].institutions[0].type | education |
| authorships[21].institutions[0].lineage | https://openalex.org/I177388780 |
| authorships[21].institutions[0].country_code | CN |
| authorships[21].institutions[0].display_name | Xuzhou Medical College |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Shibao Li |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China. [email protected]. |
| authorships[22].author.id | https://openalex.org/A5100703940 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-5846-2337 |
| authorships[22].author.display_name | Jing Jing |
| authorships[22].countries | CN |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I24185976, https://openalex.org/I4210089761 |
| authorships[22].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| authorships[22].institutions[0].id | https://openalex.org/I24185976 |
| authorships[22].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[22].institutions[0].type | education |
| authorships[22].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[22].institutions[0].country_code | CN |
| authorships[22].institutions[0].display_name | Sichuan University |
| authorships[22].institutions[1].id | https://openalex.org/I4210089761 |
| authorships[22].institutions[1].ror | https://ror.org/007mrxy13 |
| authorships[22].institutions[1].type | healthcare |
| authorships[22].institutions[1].lineage | https://openalex.org/I4210089761 |
| authorships[22].institutions[1].country_code | CN |
| authorships[22].institutions[1].display_name | West China Hospital of Sichuan University |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Jing Jing |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Institute of Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| authorships[23].author.id | https://openalex.org/A5035201433 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-9670-4031 |
| authorships[23].author.display_name | Ting Luo |
| authorships[23].countries | CN |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I24185976 |
| authorships[23].affiliations[0].raw_affiliation_string | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| authorships[23].institutions[0].id | https://openalex.org/I24185976 |
| authorships[23].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[23].institutions[0].type | education |
| authorships[23].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[23].institutions[0].country_code | CN |
| authorships[23].institutions[0].display_name | Sichuan University |
| authorships[23].author_position | last |
| authorships[23].raw_author_name | Ting Luo |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Institute of Breast Health Medicine, Breast Center, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. [email protected]. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41392-025-02337-1.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2403980124, https://openalex.org/W3014494596, https://openalex.org/W2044601662, https://openalex.org/W3101569952, https://openalex.org/W3204170562, https://openalex.org/W2793654911, https://openalex.org/W2894956186, https://openalex.org/W2772987978, https://openalex.org/W4409980568 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1038/s41392-025-02337-1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2739142469 |
| best_oa_location.source.issn | 2059-3635, 2095-9907 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2059-3635 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Signal Transduction and Targeted Therapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_name | Springer Nature |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41392-025-02337-1.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Signal Transduction and Targeted Therapy |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41392-025-02337-1 |
| primary_location.id | doi:10.1038/s41392-025-02337-1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2739142469 |
| primary_location.source.issn | 2059-3635, 2095-9907 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2059-3635 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Signal Transduction and Targeted Therapy |
| primary_location.source.host_organization | https://openalex.org/P4310319965 |
| primary_location.source.host_organization_name | Springer Nature |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s41392-025-02337-1.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Signal Transduction and Targeted Therapy |
| primary_location.landing_page_url | https://doi.org/10.1038/s41392-025-02337-1 |
| publication_date | 2025-07-21 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2889646458, https://openalex.org/W3195237310, https://openalex.org/W2096027508, https://openalex.org/W3213834237, https://openalex.org/W2402636472, https://openalex.org/W4402551965, https://openalex.org/W3087393791, https://openalex.org/W2946550606, https://openalex.org/W3006930853, https://openalex.org/W4213010786, https://openalex.org/W4405350607, https://openalex.org/W2996416715, https://openalex.org/W4281698779, https://openalex.org/W2889746019, https://openalex.org/W2345415641, https://openalex.org/W2766673799, https://openalex.org/W1816099873, https://openalex.org/W3027448020, https://openalex.org/W2067640897, https://openalex.org/W2466792968, https://openalex.org/W3006134372, https://openalex.org/W4210957314, https://openalex.org/W2606765235, https://openalex.org/W2605792367, https://openalex.org/W2944687997, https://openalex.org/W2264815585, https://openalex.org/W2561368039, https://openalex.org/W4220712828, https://openalex.org/W2807418950, https://openalex.org/W2909679049, https://openalex.org/W4280495239, https://openalex.org/W3037257919, https://openalex.org/W4405458712, https://openalex.org/W3122770844, https://openalex.org/W3127910716, https://openalex.org/W4388923847, https://openalex.org/W2082634661, https://openalex.org/W2759643796, https://openalex.org/W4319881073, https://openalex.org/W4393274156, https://openalex.org/W4404028011, https://openalex.org/W2943031211, https://openalex.org/W4400573073, https://openalex.org/W2560367415, https://openalex.org/W4229079181, https://openalex.org/W2808944387, https://openalex.org/W4211059381, https://openalex.org/W4393935425, https://openalex.org/W4226144557, https://openalex.org/W4226352036 |
| referenced_works_count | 50 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 24 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.89032351 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |